A B S T R A C T The in vitro immune response of systemic lupus erythematosus (SLE) lymphocytes to nucleosides conjugated to keyhole limpet hemocyanin (KLH) (A,G,C,T-KLH) was investigated. The nucleosides were chosen not only because they are a part of nucleic acid antigen and involved in autoimmunity, but also because nucleoside covalently bound to either soluble IgG or cells had been shown to induce unresponsiveness in mice. A significant proliferation index was induced in SLE lymphocytes, as compared with normal or rheumatoid arthritis (RA) lymphocytes in vitro [in (A,G,C,T)-KLH, 1 ,ug/ml; stimulation index = M±SE, SLE 2.10±0.26, RA 1.06±0.14, normal 1.12±0.12 P < 0.05]. Lymphocytes from SLE patients responded specifically to low doses of (A,G,C,T)-KLH and not to the protein carrier KLH alone. A solid-phase radioimmunoassay was developed to detect nucleoside-specific antibody. SLE lymphocytes spontaneously produced high levels of anti-A,G,C,T antibody. This was further increased by antigenic stimulation, but not with pokeweed mitogen (PWM) stimulation. In contrast normal lymphocytes failed to produce anti-A,G,C,T antibody either spontaneously or in response to antigen. However, normal lymphocytes produced antibody after stimulation with PWM.
More importantly, anti-A,G,C,T antibody production by SLE lymphocytes was suppressed by preincubation with A,G,C,T-IgG (A,G,C,T-HGG). The antigen-specific unresponsiveness caused by A,G,C,T-HGG was demonstrated by the observation that INTRODUCTION Systemic lupus erythematosus (SLE)' has long been considered a prototypic autoimmune disease because of its multisystem involvement and the production of multiple antibodies. A typical lupus serum can react with nucleic acid (native or denatured DNA, RNA) nucleoprotein (Sm and RNP antigens; ribosomes; nucleohistones) and cell surface antigens (1) . Antibodies to nucleic acids are particularly significant since the deposition of immune complexes of antinucleic acid antibodies with nucleic acid antigens is considered to be an important pathogenetic mechanism in SLE (2) (3) (4) (5) .
Previous studies have suggested that some of these immune abnormalities found in patients with active SLE may result from loss of suppressor T cells and/or abnormalities in their function (6) (7) (8) (9) (10) . However, those studies did not examine regulation of antibodies specific for nucleic acid determinants. In the present study, we investigated the in vitro response of SLE lymphocytes to nucleoside conjugated to keyhole limpet hemocyanin (KLH) (A,G,C,T-KLH). The nucleosides were chosen not only because they were part of nucleic acid antigens and involved in autoimmunity, but also because nucleoside covalently bound to either soluble IgG or cells had been shown to induce unresponsiveness in experimental animals (11, 12) . The results described herein demonstrate that SLE lymphocytes proliferate in response to nucleoside carrier conjugate, make nucleoside-specific antibody, and can be rendered tolerant with regard to nucleoside antibody formation in vitro with (A,G,C,T) human gamma globulin (HGG) (the nucleosides conjugated to human y-globulin).
METHODS
Antigens. HGG was isolated from the pooled sera over a DEAE-column using a 0.01 M, pH 6.8 phosphate-eluting buffer. KLH was obtained from Calbiochem-Behring Corp., Div. American Hoechst Corp., San Diego, CA, and was prepared as described elsewhere (13) . Nucleoside was conjugated to HGG, bovine serum albumin (BSA), or KLH by the procedure of Erlanger and Beiser as described previously (14) . The hapten-carrier conjugates used in this experiment are the following: (A,G,C,T)49-KLH, (A,G,C,T)14-HGG, ( Anti-A,G,C,T antibody formation in vitro. Culture conditions for anti-A,G,C,T antibody formation were the same as previously described (15) for the anti-DNP antibody response. Briefly, peripheral blood lymphocytes were cultured for 5 d with the indicated concentration of antigens or with PWM in a total volume of 200 Ml per well in flat-bottomed microtiter plates (Falcon Labware) in RPMI 1640 supplemented with 20% fetal calf serum (FCS) (Grand Island Biological Co., Grand Island, NY), 200 mM L-glutamine, 25 mM Hepes buffer, 0.5% sodium bicarbonate, and 1% penicillin-streptomycin at 370C in a humid atmosphere containing 5% CO2.
At the completion of the culture period, the cells were washed three times to remove antigen, resuspended in the same media, and incubated for 5 additional d at 370C. Culture supernatants from five individual wells were pooled and stored at -20'C until assayed for anti-A,G,C,T antibody.
Tolerance induction in vitro. Peripheral blood lymphocytes (PBL) (4 X 106/ml), resuspended in the supplemented RPMI 1640 media described above were incubated with or Radioimmunoassay for anti-A,G,C,T antibody. The radioimmunoassay (RIA) used for measurement of anti-A,G,C,T antibody in culture media was a solid phase RIA technique as described previously (15, 16) . Briefly, (A,G,C,T)-BSA was absorbed onto flexible polyvinyl plates (Cooke Laboratory Products, Alexandria, VA) at a concentration of 1 mg/ml for 2 h at 4°C. After excess (A,G,C,T)-BSA was removed, the wells were thoroughly washed and any further nonspecific binding sites were blocked by incubation with 1% BSA in phosphate-buffered saline. After additional washing, 50
Ml of culture supernatants were added to each well, incubated for 3 h at 4°C and washed three times.
Finally, 25 Mul containing 105 cpm of 125I-labeled (chloramine T method) affinity purified, rabbit anti-human F(ab')2 were added to each well. The plates were incubated overnight at 4°C. Unbound 1251 was removed by extensive washing, the plates were cut with scissors, and each well was counted for bound radioactivity in a gamma counter. Anti-A,G,C,T antibody production secreted into culture supernatants was assayed in triplicate. Background values determined by replacing the second layer culture supernatants with 20% FCS in RPMI 1640, were usually <200 cpm and were subtracted from experimental values.
Determination of Ig classes of anti-A,G,C,T antibody. The monospecific anti-human IgM and anti-human IgG sera were purchased from Miles Laboratories, Inc., Elkhart, IN, and further purified by elution from appropriate immunoabsorbent columns. These antisera were then coupled to BrCN activated Sepharose 4B as outlined by the manufacturer (Pharmacia Fine Chemicals). To determine the Ig classes of the anti-A,G,C,T antibodies, a culture supernatant aliquot was passed through a column of Sepharose 4B cou-pled with one of another antiserum, and subsequently, the anti-A,G,C,T antibody activity of the eluate was compared to the anti-A,G,C,T activity of an aliquot of culture supernatant that was passed through a column of uncoupled, unactivated Sepharose 4B.
RESULTS
Antigen-induced proliferation of PBL in vitro.
(A,G,C,T)-KLH induced proliferation by PBL from patients with SLE and RA and from normal individuals was studied. Significantly greater stimulation of SLE PBL was observed at low doses of antigen (Fig. 1) . The mean±SE, SI at 1 ,ug/ml were SLE 2.10±0.26, RA 1.06±0.14, normal 1.12±0.12 (P < 0.05). The differences were also significant at 0.1 ,ug/ml, however they were not at 10 ,ug/ml. Lymphocytes from SLE patients responded specifically to low doses of (A,G,C,T)-KLH and not to the protein carrier KLH alone (Fig. 1) . 10 ,gg/ml of either (A,G,C,T)-KLH or KLH led to good responses in normals and RA patients, as well as in SLE patients.
In vitro A,G,C, T antibody response of patients with SLE. To determine the optimal conditions for anti-A,G,C,T antibody production, varying amounts of (A,G,C,T)-KLH were added to 0.2 ml of media con- in Fig. 2 ) either spontaneously or in response to antigen. Thus, whereas normal lymphocytes could proliferate in regard to high doses of (A,G,C,T)-KLH, they could not produce antibody in response to that antigen. PWM stimulated A,G,C,T responses of normal and SLE lymphocytes. Fig. 3 compares the high spontaneous anti-A,G,C,T responses that were observed from SLE lymphocytes (7,020±850 cpm) with the minimal response by normal lymphocytes (268±80 cpm). After stimulation with PWM, the anti-A,G,C,T response by SLE lymphocytes was decreased to 4,210±542 cpm. In contrast, an increased amount of anti-A,G,C,T antibody was secreted by the normal lymphocytes (2,240±356 cpm).
Relationship between nucleoside specific immune response and disease activity of SLE. Furthermore, the relationship between nucleoside specific immune response and disease activity of SLE was examined. As shown in Table I , the patients with active SLE had both a higher stimulation index of antigen induced lymphocyte proliferation and higher spontaneous anti-A,G,C,T antibody production than patients with inactive SLE.
Specificity of the anti-A,G,C,T antibody produced.
We investigated the ability of soluble (A,G,C,T), DNP-BSA, or OA to inhibit anti-A,G,C,T antibody binding to AGCT-coated plates. After in vitro culture, (A,G,C,T), DNP-BSA, or OA were added to the culture supernatants before their addition to plastic plates previously coated with (A,G,C,T)-BSA. The supernatants were removed and the plates were washed several times before the addition of '25I-labeled rabbit antihuman F(ab')2. As shown in Table II , addition of (A,G,C,T) to the culture supernatant resulted in a marked decrease in antibody binding while the addition of DNP-BSA or OA resulted in only minimal inhibition of anti-A,G,C,T antibody binding. These results suggest that the antibody produced was A,G,C,Tspecific. Characterization of anti-A,G,C,T antibody class. To determine the class of anti-A,G,C,T antibody-pro- duced culture supernatants were passed through both anti-human IgM and anti-IgG conjugated Sepharose 4B columns and the eluate was examined for residual anti-A,G,C,T antibody activity by RIA. As a control, the culture supernatants were also passed through an unconjugated Sepharose 4B column. SLE supernatants were from A,G,C,T-stimulated cultures. Normals did not produce enough antibody following (A,G,C,T)-KLH stimulation for such an analysis. Therefore, PWM-induced antibody from normals was studied. Table III shows that in PWM-stimulated normal culture supernatants, an anti-IgM column could remove >80% of the anti-A,G,C,T antibody binding activity, whereas an anti-IgG column had a minimal effect. In contrast, in A,G,C,T stimulated culture supernatants of SLE, an anti-IgG column could remove >60% of the anti-A,G,C,T antibody binding activity, whereas the anti-IgM column removed less anti-A,G,C,T antibody binding activity. These results demonstrate that anti-A,G,C,T antibody produced by SLE lymphocytes was predominantly of the IgG isotype and that anti-A,G,C,T antibody produced by normals after stimulation with PWM was primarily of the IgM isotype. A,G,C,T-specific inhibition of antibody production by preincubation with A,G,C,T-HGG conjugates. The effect of in vitro incubation of lymphocytes with various conjugates on the anti-A,G,C,T antibody response was assessed in the SLE patients whose lymphocytes produced a large amount of anti-A,G,C,T antibody. As shown in Fig. 4 , lymphocytes preincubated without antigen produced 12,000±900 cpm of anti-A,G,C,T antibody. In contrast, preincubation with Culture supernatants were passed through affinity purified goat anti-human IgM and antiIgG conjugated Sepharose 4B columns. As a control, culture supernatants were passed through a Sepharose 4B column. Values are expressed as the mean counts per minute/culture±SE of triplicate samples.
In addition to this, preincubation with A,G,C,T-human serum albumin did not show any suppression of anti-A,G,C,T response (Table IV) . These results suggest that preincubation with (A,G,C,T)-HGG can induce hapten (A,G,C,T)-specific tolerance in vitro. To determine whether (A,G,C,T)-HGG causes specific unresponsiveness, the anti-DNP response of these tolerizing cells was also examined (Fig. 5 ). Although preincubation with (A,G,C,T)-HGG did not affect the production of anti-DNP antibody response, the anti-A,G,C,T antibody response was inhibited. As expected, preincubation with (A,G,C,T)-KLH or BPO-HGG did not affect either the anti-A,G,C,T response or the anti-DNP response. These results demonstrate that the suppression of the anti-A,G,C,T response was antigen specific. rier conjugate, (A,G,C,T)-KLH. Furthermore, anti-A,G,C,T-specific antibody production by lymphocytes from SLE was suppressed by preincubation with A,G,C,T IgG (A,G,C,T-HGG). The antigen-specific unresponsiveness caused by (A,G,C,T)-HGG was demonstrated by the observation that preincubation with (A,G,C,T)-HGG did not affect the production of anti-DNP antibody response. SLE lymphocytes, but not normal and RA lymphocytes, proliferated in response to stimulation by low doses (0.1 or 1.0 tig/ml) of (A,G,C,T)-KLH. This result is consistent with studies demonstrating that SLE lymphocytes had sensitized to nuclear antigen (17, 18) . In other studies, SLE lymphocytes cultured with native DNA produced a macrophage migration inhibitory factor that also suggests that there are circulating DNA-sensitized lymphocytes (19) .
SLE lymphocytes spontaneously produced high levels of anti-A,G,C,T antibody. This was further increased by antigenic stimulation, but not PWM stimulation. In contrast, normal lymphocytes produced antibody only after stimulation with PWM. The spontaneous high production of anti-A,G,C,T by SLE lymphocytes is consistent with studies demonstrating that lymphocytes from active SLE produced spontaneously large quantities of immunoglobulin in vitro and an increased number of B cells defined by monoclonal anti-Bi (20) (21) (22) . These include autoantibodies, such as DNA, and antibodies to specificities thought to be unrelated to self antigens such as trinitrophenyl (23) (24) (25) (26) . It is also reported that lymphocytes from SLE patients had a markedly depressed in vitro response to PWM with regad to Ig synthesis (21, 27) . Similarly, the A,G,C,T-specific antibody response by SLE lymphocytes was decreased following stimulation with PWM. This greater stimulation index of SLE lymphocytes as well as the spontaneous high levels of anti-A,G,C,T antibody by SLE lymphocytes were correlated well with disease activity.
After polyclonal stimulation by PWM, an increased amount of anti-A,G,C,T antibody was obtained from cultures of normal lymphocytes. The immunoglobulin class of the anti-A,G,C,T antibody produced by normal lymphocytes belongs mainly to the IgM class, anti-A,G,C,T antibody produced by SLE lymphocytes was predominantly IgG. In this regard, Bankhurst et al. showed that normal individuals had DNA binding lymphocytes but that they occurred in smaller numbers than in SLE (23) . More recently, it has been reported that after Epstein-Barr virus transformation, normal B cells can produce DNA antibody although these lymphocytes did not produce such antibody spontaneously (28) . Our results suggest that normal lymphocytes contain precursors of B cells capable of producing anti-nucleoside antibody. Further studies are needed to define the fine specificity of the antinucleoside antibody in the culture supernatant utilizing either isolated nucleosides, polynucleosides, or single-stranded DNA. Nucleoside-specific tolerance could be induced in vitro by incubating SLE lymphocytes with (A,G,C,T)-HGG. Preincubation with A,G,C,T conjugated to HSA did not result in the suppression of anti-A,G,C,T response, indicating that not all conjugates of A,G,C,T to self antigens were necessarily tolerogenic. These results extended the observations on DNP specific tolerance induced by DNP-HGG to antigenic determinants relevant to autoimmunity in humans.2 Initially, in experimental animals, tolerance was induced in (NZB X NZW) F1 mice by the administration of a synthetic nucleic acid plus cyclophosphamide (29) . Subsequently, Borel et (11) . The prolonged administration of denatured DNA noncovalently complexed to poly D-lysine also prevented the appearance of antibody to denatured DNA (28) . Similarly, successful induction of tolerance to nucleic acid determinants was induced by administration of nucleoside conjugates of D-GL (31) .
It appears that the suppression of SLE antibody to nucleic acid antigens can now be achieved in vitro by inducing tolerance with nucleic acid linked to human IgG in cultured lymphocytes sensitized to nucleic acid antigen. Although DNA antigenic determinants larger than nucleosides are required to induce tolerance to DNA in SLE patients (32) , the data suggests that an ongoing immune response can be influenced in vitro by inducing tolerance with nucleic acid linked to human IgG.
